• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Decreasing incidence of heart failure observed in Ontario, Canada

bys25qthea
October 15, 2012
in Cardiology, Pulmonology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: CC/JHeilman. Pulmonary edema in heart failure. 

Key findings:

  1. This study noted a substantial decrease in the incidence of heart failure in Ontario during the study period, with the largest declines in the oldest age group
  2. There was a modest improvement observed in 1-year mortality but results were inconsistent between inpatient and outpatient groups

Primer: Heart failure has been associated with high morbidity and mortality rates and is a significant burden on health care systems. Cardiovascular disease is a leading cause of death globally and heart failure specifically is a common cause of hospital admission. Heart failure is characterized by dyspnea and fatigue caused by reduced ability of the heart to deliver sufficient oxygen to tissues.

Trends in the incidence of heart failure and other cardiovascular events have been changing over time with rapidly increasing rates observed in the 1990s and more recently, no change or declines in hospital admissions due to heart failure. This large, population-based cohort study contributes to the body of evidence suggesting a decrease in incidence of heart failure.

For further reading regarding, please see the following studies:

  1. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292(3):344-350.
  2. Tu JV, Nardi L, Fang J, et al. National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ 2009;180(13):E118-125.

This [population-based] study: This population-based study reviewed patients who were diagnosed with heart failure for the first time between April 1, 1997 and March 31, 2008. Inpatient and outpatient data were collected from the Canadian Institute for Health Information’s (CIHI) Discharge Abstract Database and the Ontario Health Insurance Plan (OHIP) physicians claims database, respectively. A heart failure event was considered as 1 documented admission for heart failure alone, or 1 outpatient claim for heart failure followed by at least 1 additional outpatient heart failure claim within 1 year, using the 2-claim method.

RELATED REPORTS

Structured exercise intervention improves survival in colon cancer patients

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Cerebral embolic protection does not decrease stroke incidence in TAVI patients

This study identified 419,551 incident cases of heart failure in Ontario from 1997-2007. The age- and sex-standardized incidence of heart failure significantly decreased in both inpatient and outpatient settings. The 1-year risk-adjusted mortality significantly decreased among all patients, with a significant decrease among outpatients and a nonsignificant decrease among inpatients. Both the 1-year risk-adjusted rate of readmission for heart failure and the 1-year risk-adjusted all-cause readmission rate decreased significantly.

In sum: The results of this study were promising, showing a substantial decrease in the incidence of heart failure in Ontario between 1997 and 2007; however, only modest improvement was observed in prognosis for patients with heart failure. Although the 2-claim method improved the specificity of case selection, this may have led to an underestimate of the incidence of heart failure. A strength of the investigation was the inclusion of outpatients, since most previous studies have not included ambulatory data and this group accounts for roughly half of new cases. This is also the largest and most recent population-based study showing a decreasing trend in the incidence of heart failure. Possible explanations for the decline include declines in cases of ischemic heart disease (i.e., a leading cause of heart failure) and improved prevention of ischemic heart disease by addressing risk factors such as smoking and hypertension.

Click to read in CMAJ

Written by [AdC] and [AC]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

Prognostic messages for cerebral palsy developed from a systematic review of the literature

Next Post

The HOPE trial: Ramipril significantly reduces cardiovascular events in high-risk patients with normal ejection fractions [Classics Series]

RelatedReports

Development of a risk index for colorectal cancer screening
Gastroenterology

Structured exercise intervention improves survival in colon cancer patients

July 9, 2025
#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025
Cerebral protection device effective in patients undergoing transcatheter aortic valve implantation
Cardiology

Cerebral embolic protection does not decrease stroke incidence in TAVI patients

July 8, 2025
Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT
Pharma

Nerandomilast slows FVC decline in progressive pulmonary fibrosis

July 8, 2025
Next Post
Classics Series, Landmark Trials in Medicine

The HOPE trial: Ramipril significantly reduces cardiovascular events in high-risk patients with normal ejection fractions [Classics Series]

Increased blood pressure variability during the subacute stage of ischemic stroke is associated with worsened functional outcomes at 3 months

A phase I trial of neural stem cells in a disease of myelination shows promising results

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Structured exercise intervention improves survival in colon cancer patients
  • #VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
  • Cerebral embolic protection does not decrease stroke incidence in TAVI patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.